Alosetron

🧮 Dose calculator

Functional bowel / irritable bowel syndrome · Regimen source: FDA Alosetron · 2.1

• • Stop at once if constipated; after resolution restart at 0.5 mg once daily; stop permanently if it recurs. Stop if not controlled after 4 weeks at 1 mg twice daily. FDA Alosetron · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Alosetron · 8.1

  “Risk Summary The available data with alosetron tablets use in pregnant women are insufficient to draw conclusions about any drug-associated risks for major birth defects, miscarriage, or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Alosetron · 8.2

  “Risk Summary There are no data regarding the presence of alosetron in human milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Alosetron · 8.4

  “Safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Alosetron · 8.5

  “In some studies in healthy men or women, plasma concentrations were elevated by approximately 40% in individuals 65 years and older compared to young adults [see Warnings and Precautions ( 5.1 )] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.